Medication Use and Metabolic Syndrome Among Overweight/Obese Patients With and Without Binge-Eating Disorder in a Primary Care Sample.
Medication Use and Metabolic Syndrome Among Overweight/Obese Patients With and Without Binge-Eating Disorder in a Primary Care Sample.
复制标题
DOI：
10.4088/pcc.15m01816
复制
发表时间：
2015-01-01
影响因子：
--
通讯作者：
Barnes, Rachel D
中科院分区：
文献类型：
--
作者：
Barber, Jessica A;Schumann, Kristina P;Barnes, Rachel D
目的：研究超重/肥胖个体与暴饮暴食症（BED）和非暴饮暴食超重/肥胖（NBO）患者从初级保健招募的代谢因素，并检查和比较这些groups.METHOD的药物使用：参与者是102名成年人招募的减肥研究在初级保健中心谁被评估为BED（28 [38%]符合DSM-5 BED标准）。参与者填写药物日志，进行生理测量，并使用2种方法评估代谢综合征的存在。结果：BED组平均体重指数（BMI）、脉搏、腰围均高于NBO组。在样本中，65%报告了当前药物使用情况（处方药和/或非处方药）：19.6%使用3 - 4种药物，15.7%使用≥ 5种药物。除了维生素和非处方抗过敏药的使用外，BED和NBO患者之间的药物使用没有差异。当仅使用客观测量时，31.5%的样本存在完全代谢综合征（满足≥ 3项标准），当通过客观测量和药理学管理定义时，39.1%的样本存在完全代谢综合征。无显着差异，观察到无论definition.CONCLUSIONS：尽管较高的BMI，脉搏，腰围，目前的样本BED患者在初级保健并不存在较差的代谢健康比NBO患者。
OBJECTIVE: To examine metabolic factors among overweight/obese individuals with binge-eating disorder (BED) and non-binge-eating overweight/obese (NBO) patients recruited from primary care and to examine and compare medication use by these groups.METHOD: Participants were 102 adults recruited for a weight loss study within primary care centers who were assessed for BED (28 [38%] met DSM-5 BED criteria). Participants completed a medication log, had physiologic measurements taken, and were evaluated for the presence of metabolic syndrome using 2 methods. Data were collected between February 2012 and October 2012.RESULTS: The BED group had a higher mean body mass index (BMI), a higher pulse, and a larger waist circumference than the NBO group. Of the sample, 65% reported current medication use (prescription and/or over-the-counter medications): 19.6% took 3 to 4 medications and 15.7% took ≥ 5 medications. Aside from vitamin and over-the-counter allergy pill use, there were no differences in medication use between BED and NBO patients. Full metabolic syndrome (≥ 3 criteria met) was present in 31.5% of the sample when using objective measurement alone, and 39.1% of the sample when defined by objective measurement and pharmacologic management. No significant differences were observed regardless of definition.CONCLUSIONS: Despite higher BMI, pulse, and waist circumference, the current sample of BED patients in primary care did not present with poorer metabolic health than NBO patients.